Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata request) on April 4, 2017. The report announces consolidated financial results for the third quarter of fiscal year 2017, ended February 26, 2017.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It serves solely as a notification that the results have been issued via a press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. The registrant explicitly states that the information in this report and Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation, not Lifecore Biomedical, Inc.
- Locate and review Exhibit 99.1 (Press Release dated April 4, 2017) for actual financial figures.
- Confirm the fiscal quarter end date of February 26, 2017.
- Note that the 8-K itself does not incorporate the financial data by reference for liability purposes under Section 18.